Occurrence of bicuculline-, NMDA- and kainic acid-induced seizures in prenatally methamphetamine-exposed adult male rats

. 2005 Nov ; 372 (3) : 236-41. [epub] 20051025

Jazyk angličtina Země Německo Médium print-electronic

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid16247608

Stimulant drugs are often associated with increased seizure susceptibility. Inhibitory gamma-aminobutyric acid (GABA) and excitatory N-methyl-D-aspartate (NMDA) systems play an important role in the effect of stimulants on epileptic seizures. No studies investigating the effect of prenatal methamphetamine (MA) exposure on seizures are available. In this study, bicuculline (GABAA receptor antagonist), NMDA (NMDA receptor agonist) and kainic acid (non-NMDA receptor agonist) were used to induce seizures in adult male rats. Three groups of animals were tested in each seizure test: prenatally MA- (5 mg/kg) exposed, prenatally saline-exposed, and absolute controls without any prenatal exposure. In bicuculline-induced seizures, the latency to onset of tonic-clonic seizures was shorter in MA-exposed rats than in controls, but it did not differ from saline-exposed rats. There were no differences in clonic seizure onset between groups. In NMDA-induced seizures, the latency to onset of clonic-tonic seizures was shorter in prenatally MA-exposed rats than in controls; however, the latency to onset of saline-exposed animals did not differ from either MA-exposed or from control rats. There were no differences in seizure susceptibility in kainic acid-induced clonic seizures. There were no differences in seizure incidences or stereotypical behavior in any seizure model. The question remains as to how much the present data demonstrate the effect of prenatal drug exposure on seizure susceptibility per se, and how much they may be explained by the effect of prenatal stress or by other mechanism(s).

Zobrazit více v PubMed

Epilepsy Behav. 2004 Dec;5(6):852-6 PubMed

Dev Psychobiol. 1975 May;8(3):261-8 PubMed

Synapse. 1996 Mar;22(3):217-25 PubMed

Neuroscience. 2004;126(2):355-64 PubMed

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Jan;30(1):82-8 PubMed

Pharmacol Biochem Behav. 2000 Jan 1;65(1):39-42 PubMed

Trends Pharmacol Sci. 1990 Jul;11(7):290-6 PubMed

Brain Res Dev Brain Res. 2005 Jun 30;157(2):217-9 PubMed

J Neurosci. 1994 May;14(5 Pt 1):2697-707 PubMed

Neurosci Lett. 1999 Jun 18;268(2):81-4 PubMed

Exp Neurol. 1986 Sep;93(3):546-56 PubMed

Brain Res. 2001 Dec 20;922(2):305-9 PubMed

Neurology. 1994 Nov;44(11 Suppl 8):S14-23 PubMed

Life Sci. 1993;53(26):1947-56 PubMed

J Pharmacol Exp Ther. 1992 Sep;262(3):936-46 PubMed

J Neurophysiol. 1997 Jan;77(1):126-36 PubMed

Curr Opin Neurol Neurosurg. 1992 Apr;5(2):216-23 PubMed

Neuroscience. 1999 Mar;90(3):833-50 PubMed

Pharmacol Biochem Behav. 2004 Jul;78(3):495-504 PubMed

Horm Behav. 2002 Dec;42(4):437-47 PubMed

Pol J Pharmacol. 2001 Jan-Feb;53(1):57-60 PubMed

Neurol Clin. 1993 Aug;11(3):563-75 PubMed

Dev Psychobiol. 2005 Jan;46(1):57-65 PubMed

Brain Res Dev Brain Res. 1997 Sep 20;102(2):189-96 PubMed

J Neurosci. 1996 Jan;16(1):274-82 PubMed

Ann N Y Acad Sci. 2000;909:217-32 PubMed

Brain Res. 1988 May 10;448(1):20-9 PubMed

Dev Psychobiol. 1999 Apr;34(3):227-34 PubMed

Epilepsia. 2002;43 Suppl 2:28-31 PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...